Clinical Trial Update: A Study of Tafetinib in Chinese Patients With Advanced Solid Tumor [Phase 1]

View source ↗

Summary

Phase 1 trial assessing Tafetinib in Chinese patients with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• Tafetinib

Snippet

Sponsor: Nanjing Yoko Biomedical Co., Ltd. | Conditions: Neoplasms | Phase 1 | Status: UNKNOWN